(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DERMAVANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DERMAVANT

ST13

US500000087788429

Class

5, 44

Filing

87788429

Registration

5796949

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

02/24/2026

Trademark type

Word

Nice classes

5, 44

Filing date

02/07/2018

Registration date

07/09/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/03/2026

Last transaction

02/24/2026

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Luzern, CH

Examiner

BELENKER, ESTHER

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Dermavant Sciences GmbH
Dermavant Sciences GmbH

Representatives

James A. Thomas

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biological preparations for medical purposesto treat dermatological conditions

Class 44

Providing health and medical information via a website; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions via a website

Publications

History of USPTO decisions and trademark events.

35 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/03/2026

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/03/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/03/2026

E815

TEAS SECTION 8 & 15 RECEIVED

10/30/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/28/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/28/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/28/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/28/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/28/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/28/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2019

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/30/2019

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/29/2019

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/18/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/20/2018

PUBO

PUBLISHED FOR OPPOSITION

11/20/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/31/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/12/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

10/04/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/04/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

10/04/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/04/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/01/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2018

ALIE

ASSIGNED TO LIE

09/30/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2018

DOCK

ASSIGNED TO EXAMINER

08/10/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/22/2018

GNRT

NON-FINAL ACTION E-MAILED

05/22/2018

CNRT

NON-FINAL ACTION WRITTEN

05/22/2018

DOCK

ASSIGNED TO EXAMINER

05/22/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/15/2018

NWAP

NEW APPLICATION ENTERED

02/10/2018

Continuous trademark protection

Get notified about every new filing that threatens DERMAVANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.